SQUAWK/NEWS
Menu
Live News REGULATION L impact

SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing

SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing

SBFM

SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing